Infectious diseases, comorbidities and outcomes in hospitalized people who inject drugs (PWID) infections in persons who inject drugs.
Journal
PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081
Informations de publication
Date de publication:
2022
2022
Historique:
received:
05
04
2021
accepted:
24
03
2022
entrez:
20
4
2022
pubmed:
21
4
2022
medline:
23
4
2022
Statut:
epublish
Résumé
Injection drug use poses a public health challenge. Clinical experience indicates that people who inject drugs (PWID) are hospitalized frequently for infectious diseases, but little is known about outcomes when admitted. Charts were identified from local hospitals between 2013-2018 using consultation lists and hospital record searches. Included individuals injected drugs in the past six months and presented with infection. Charts were accessed using the hospital information system, undergoing primary and secondary reviews using Research Electronic Data Capture (REDCap). The Wilcoxon rank-sum test was used for comparisons between outcome categories. Categorical data were summarized as count and frequency, and compared using Fisher's exact test. Of 240 individuals, 33% were admitted to the intensive care unit, 36% underwent surgery, 12% left against medical advice (AMA), and 9% died. Infectious diagnoses included bacteremia (31%), abscess (29%), endocarditis (29%), cellulitis (20%), sepsis (10%), osteomyelitis (9%), septic arthritis (8%), pneumonia (7%), discitis (2%), meningitis/encephalitis (2%), or other (7%). Sixty-six percent had stable housing and 60% had a family physician. Fifty-four percent of patient-initiated discharges were seen in the emergency department within 30 days and 29% were readmitted. PWID are at risk for infections. Understanding their healthcare trajectory is essential to improve their care.
Identifiants
pubmed: 35443003
doi: 10.1371/journal.pone.0266663
pii: PONE-D-21-11155
pmc: PMC9020696
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0266663Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
Am J Public Health. 2013 Jan;103(1):105-11
pubmed: 23153145
Am J Public Health. 2020 Jan;110(1):45-50
pubmed: 31725310
AIDS Care. 2015;27(9):1128-36
pubmed: 25915438
Am J Public Health. 2015 Dec;105(12):e53-9
pubmed: 26469651
J Urban Health. 2011 Jun;88(3):545-55
pubmed: 21409604
Int J Drug Policy. 2012 Jul;23(4):261-70
pubmed: 22579215
Epidemiol Perspect Innov. 2011 Feb 02;8(1):1
pubmed: 21288353
AIDS Care. 2018 Sep;30(9):1099-1106
pubmed: 29397766
Harm Reduct J. 2017 May 12;14(1):16
pubmed: 28494791
J Prim Care Community Health. 2020 Jan-Dec;11:2150132720908370
pubmed: 32100617
Open Forum Infect Dis. 2020 Mar 03;7(3):ofaa074
pubmed: 32258203
BMC Public Health. 2008 Dec 09;8:405
pubmed: 19068133
Sex Transm Infect. 2006 Jun;82 Suppl 3:iii56-63
pubmed: 16735295
Can Commun Dis Rep. 2014 Dec 18;40(19):429-436
pubmed: 29769874
Harm Reduct J. 2018 Nov 12;15(1):55
pubmed: 30419926
Soc Sci Med. 2014 Mar;105:59-66
pubmed: 24508718
J Biomed Inform. 2019 Jul;95:103208
pubmed: 31078660
BMJ Open. 2020 Aug 13;10(8):e035188
pubmed: 32792428